Tamboran Resources Corp. (Uplisting)

We are an early stage, growth-driven independent natural gas exploration and production (E&P) company focused on an integrated approach to the commercial development of the natural gas resources in the Beetaloo located within the Northern Territory of Australia. (Incorporated in Delaware) We and our working interest partners have exploration permits (“EPs”) to approximately 4.7 million contiguous […]

May 4, 2024 Read More

TessPay

We offer a blockchain platform for financial transactions. (Incorporated in Delaware)  We have developed a financial technology platform for securing and streamlining financial transactions (the “Platform”) that utilizes blockchain technology to provide payment assurance and liquidity through a finance supply chain. Our Platform makes use of smart contracts, as programmatic representations of the terms of […]

April 30, 2024 Read More

HW Electro Co., Ltd. (NASDAQ-New Filing)

We are the first company in Japan to obtain a license plate number for imported electric light commercial vehicles. We are the second company and also one of the three companies that sell electric light commercial vehicles in Japan as of the date of this prospectus. (Incorporated in Japan)  The electric light commercial vehicles we […]

Read More

DT Cloud Star Acquisition Corp.

We are a blank check company (special-purpose acquisition company or SPAC) based in Brooklyn, N.Y. (Incorporated in the Cayman Islands) We have not selected an industry or a sector as our focus. We will focus our search for a target company (to look for a company) that has compelling economics, potential for high recurring revenue, a […]

Read More

Green Circle Decarbonize Technology Limited

Green Circle Decarbonize Technology Limited is going public via a unit IPO. The company is offering stock and warrants. This is a NASDAQ listing. (Incorporated in the Cayman Islands) Note: Loss and revenue figures are in U.S. dollars (converted from Hong Kong dollars) for the year that ended March 31, 2023 Our mission is to […]

April 29, 2024 Read More

Super Hi International Holding

Note: The prospectus calls this offering a U.S.  IPO – and the offering will consist of American Depositary Shares (ADS). But the prospectus also says that Super Hi is listed on the Hong Kong Stock Exchange under “9658” – the stock symbol. We operate hot pot restaurants in the international market under the Haidilao brand […]

April 26, 2024 Read More

NANO Nuclear Energy

We are an early-stage nuclear energy company developing smaller, cheaper, and safer advanced portable clean energy solutions utilizing proprietary reactor designs, intellectual property and research methods, illuminating our path toward a sustainable future. (Incorporated in Nevada)  Led by a world class scientific and management team, envisioned within our business plan is a comprehensive engagement across […]

Read More

GP-Act III Acquisition Corp. (New 2024 Filing)

Note: GP-Act III Acquisition Corp. filed a new S-1 on April 19, 2024, with plans for its SPAC IPO: 25.0 million units at $10.00 each to raise $250.0 million. Each unit consists of  one share of common stock and one half of a warrant. Note: This new IPO filing follows the withdrawal of its previous […]

April 22, 2024 Read More

CleanCore Solutions, Inc.

(Note: CleanCore Solutions, Inc. is the company’s name on the SEC documents. This is the same company that previously was identified as CleanCore Technologies, Inc.) CleanCore Solutions, Inc.  specializes in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial or home use. (Incorporated in Nevada) We have a patented nanobubble […]

Read More

Lirum Therapeutics

We are an innovative, clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities. (Incorporated in Delaware)  Our lead product candidate, LX-101, is a novel, clinical-stage, next generation, targeted therapy directed to the insulin-like growth […]

Read More